Genesis Therapeutics Is An Ai Driven Biotechnology Company Based In Burlingamecaliforniawith A Laboratory In San Diegothe Company Focuses On Accelerating Drug Discovery Using Advanced Machine Learning And Molecular Simulation Technologiesspecializing In Small Molecule Drug Discovery For Challenging Targets The Core Technology Of Genesis Is The Gems Platformwhich Integrates Generative Aipredictive Modelingand Molecular Simulations To Design And Optimize Drug Candidatesthis Platform Allows For The Proposal Of Novel Molecular Structuresevaluation Of Drug Target Interactionsand Analysis Of Molecular Structures In Three Dimensions Genesis Operates Through An Internal Pipeline That Develops Proprietary Drug Candidates And Engages In Strategic Partnerships With Major Pharmaceutical Companiesincluding Eli Lillygenentechgilead Sciencesand Incytethe Company Has Raised Over $300 Million From Prominent Investorsincluding Andreessen Horowitz And Nvidia S Nventuresto Support Its Mission Of Addressing Severe Health Conditions Through Innovative Drug Discovery
